New WEBINAR: Thurs 18 August - Cytokines and Receptors in Cancer Immunotherapy - Learn more here MarketingScience SharingScience SciComms Webinars
Cytokines are a key area of interest in cancer immunotherapy. Interleukin -2, IL-4, IL-7, IL-9, IL-15, and IL-21 comprise a cytokine family based on sharing a receptor component, the common cytokine receptor γ chain . γc family cytokines generally activate three major signaling pathways to regulate the development, survival, proliferation, differentiation, and function of cells in both the innate and adaptive immune systems.
Recently, designer cytokines for γc family have shown significant therapeutic potential in cancer, allergy, immunodeficiency, and autoimmunity. This webinar will discuss the critical biological roles and therapeutic applications of γc cytokines and receptors.Role of common gamma chain cytokines in cancer immunotherapySylvia Xie is a Product Scientist at Sino Biological US Inc.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Police seize almost 250,000 illegal tablets set for NI addressesPolice (PoliceServiceNI) seize almost 250,000 illegal and unlicensed tablets that were set for addresses throughout Northern Ireland
Weiterlesen »
Police seize almost 250,000 illegal tablets set for NI addressesThe illegal and unlicensed drugs included diazepam, pregabalin and the breast cancer drug tamoxifen.
Weiterlesen »
'Nothing prepares you to hear the word cancer next to your child's name'“Nothing prepares you to hear the word cancer next to your child’s name”
Weiterlesen »
Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in bloodHerein we report the use of Chaperonin-Containing TCP-1 (CCT or TRiC) as a marker to detect circulating tumor cells (CTCs) that are shed from tumors during oncogenesis. Most detection methods used in liquid biopsy approaches for enumeration of CTCs from blood, employ epithelial markers like cytokeratin (CK). However, such markers provide little information on the potential of these shed tumor cells, which are normally short-lived, to seed metastatic sites. To identify a marker that could go beyond enumeration and provide actionable data on CTCs, we evaluated CCT. CCT is a protein-folding complex composed of eight subunits. Previously, we found that expression of the second subunit (CCT2 or CCTβ) inversely correlated with cancer patient survival and was essential for tumorigenesis in mice, driving tumor-promoting processes like proliferation and anchorage-independent growth. In this study, we examined CCT2 expression in cancer compared to normal tissues and found statistically significant increases in tumors. Because not all blood samples from cancer patients contain detectable CTCs, we used the approach of spiking a known number of cancer cells into blood from healthy donors to test a liquid biopsy approach using CCT2 to distinguish rare cancer cells from the large number of non-cancer cells in blood. Using a clinically validated method for capturing CTCs, we evaluated detection of intracellular CCT2 staining for visualization of breast cancer and small cell lung (SCLC) cancer cells. We demonstrated that CCT2 staining could be incorporated into a CTC capture and staining protocol, providing biologically relevant information to improve detection of cancer cells shed in blood. These results were confirmed with a pilot study of blood from SCLC patients. Our studies demonstrate that detection of CCT2 could identify rare cancer cells in blood and has application in liquid biopsy approaches to enhance the use of minimally invasive methods for cancer diagnosis.
Weiterlesen »
Doctor banned over misleading child cancer fearsHe ran a private health firm in Glasgow where he created 'unwarranted concern' for families.
Weiterlesen »
Researchers report genomic profiling from more than 110,000 tumorsResearchers report genomic profiling from more than 110,000 tumors AACR DukeHealth Sagebio DanaFarber VUMChealth genome tumor cancer genetics genome
Weiterlesen »